These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37300525)

  • 1. Significant discordance between point of care BNP values obtained by the i-STAT and the Beckman DXI 800, causing confusion in patient management when both methods are used interchangeably by clinicians.
    Zinn K; Boyd M; Dasgupta A
    Scand J Clin Lab Invest; 2023 Jul; 83(4):278-281. PubMed ID: 37300525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the diagnostic characteristics of two B-type natriuretic peptide point-of-care devices.
    Ro R; Thode HC; Taylor M; Gulla J; Tetrault E; Singer AJ
    J Emerg Med; 2011 Dec; 41(6):661-7. PubMed ID: 21620610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of capillary B-type natriuretic peptide testing.
    Schreinlechner M; Mrakovic A; Laschober G; Mayerl C; Griesmacher A; van Lippen L; Semjonow V; Nieuwenhuis J; van Reenen A; Mair J
    Clin Chem Lab Med; 2020 Mar; 58(4):618-624. PubMed ID: 31804953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparability of Results between Point-of-Care and Automated Instruments to Measure B-type Natriuretic Peptide.
    Shah K; Terracciano GJ; Jiang K; Maisel AS; Fitzgerald RL
    West J Emerg Med; 2010 Feb; 11(1):44-8. PubMed ID: 20411075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference between Abbott AxSYM BNP and Triage BNP (Beckman Coulter DxI 800) concentrations.
    Hawkins RC
    Clin Chim Acta; 2008 Jul; 393(2):134. PubMed ID: 18423380
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study.
    Morbach C; Buck T; Rost C; Peter S; Günther S; Störk S; Prettin C; Erbel R; Ertl G; Angermann CE;
    Clin Res Cardiol; 2018 Feb; 107(2):95-107. PubMed ID: 29143161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of blood gas results obtained on Abbott i-Stat® and on Radiometer ABL 800 Flex® analyzers Impact for the clinical decision.
    Jouffroy R; Laney M; Leguillier T; Nivet-Antoine V; Beaudeux JL
    Ann Biol Clin (Paris); 2022 Nov; 80(6):521-525. PubMed ID: 36696550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Meritas® BNP Test for Point-of-Care Testing.
    Olausson J; Peterson C; Bergström M; Larsson A
    Clin Lab; 2015; 61(7):727-30. PubMed ID: 26299071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is heparin plasma suitable for the determination of B-type natriuretic peptide on the Beckman-Coulter Access 2?
    Santos H; Cauliez B; Tron C; Brunel V; Lavoinne A
    Clin Chem Lab Med; 2010 Mar; 48(3):399-401. PubMed ID: 20113257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin plasma sampling as an alternative to EDTA for BNP determination on the Access-Beckman Coulter--effect of storage at -20 degrees C.
    Dupuy AM; Terrier N; Dubois M; Boularan AM; Cristol JP
    Clin Lab; 2006; 52(7-8):393-7. PubMed ID: 16955639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of B-type natriuretic peptide (BNP) testing.
    Cowie MR; Jourdain P; Maisel A; Dahlstrom U; Follath F; Isnard R; Luchner A; McDonagh T; Mair J; Nieminen M; Francis G
    Eur Heart J; 2003 Oct; 24(19):1710-8. PubMed ID: 14522565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performance of a single epitope B-type natriuretic peptide sandwich immunoassay on the Minicare platform for point-of-care diagnostics.
    Reenen AV; Berger M; Moreau E; Bekx E; Bruinink T; Kemper D; Lippen LV; Weusten J; Mrakovic A; Michielsen E; Vissers J; Theije F; Nieuwenhuis J; Semjonow V; Mair J
    Pract Lab Med; 2019 May; 15():e00119. PubMed ID: 30984810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for a BNP standard: Glycosylated proBNP as a common calibrator enables improved comparability of commercial BNP immunoassays.
    Semenov AG; Tamm NN; Apple FS; Schulz KM; Love SA; Ler R; Feygina EE; Katrukha AG
    Clin Biochem; 2017 Mar; 50(4-5):181-185. PubMed ID: 27823960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of point-of-care B-type natriuretic peptide (BNP) measurement on medical decision-making for older emergency department patients with dyspnea.
    Kosowsky JM; Weiner C; Aronson AA; Morrissey JH
    J Emerg Med; 2006 Aug; 31(2):147-50. PubMed ID: 17044575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors.
    Alawieh H; Chemaly TE; Alam S; Khraiche M
    Sensors (Basel); 2019 Nov; 19(22):. PubMed ID: 31744130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery.
    St Peter JV; Hartley GG; Murakami MM; Apple FS
    Clin Chem; 2006 Apr; 52(4):680-5. PubMed ID: 16497939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity.
    Naik GO; Moe GW
    Clin Chem Lab Med; 2007; 45(10):1353-9. PubMed ID: 17663629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of the Architect brain natriuretic peptide (BNP) assay: a two site study.
    Mongia SK; La'ulu SL; Apple FS; Ler R; Murakami MM; Roberts WL
    Clin Chim Acta; 2008 May; 391(1-2):102-5. PubMed ID: 18294456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.